Mestinon For Fibromyalgia

Mestinon for Fibromyalgia Could Be For you.

People who have been diagnosed with fibromyalgia suffer from wide-spread pain, fatigue and muscle weakness. Mestonin was first approved by the Food and Drug Administration (FDA) in 1955 to treat myasthenia gravis, a disease characterized by muscle weakness and fatigue, and now proves beneficial in treating fibromyalgia. Solvay Pharmaceuticals, Inc., gained approval from the FDA to produce 30 mg tablets of the drug in 1990. In 1994, Solvay Pharmaceuticals withdrew their request for approval of the drug from the FDA and mestinon was discontinued. The FDA has stated that the withdrawl of the drug was not due to safety or ineffectiveness.

Mestinon prevents a chemical called acetylcholine from breaking down in the body. Acetylcholine is a chemical that controls nerve impulses, which is a concern for fibromyalgia patients. Fibromyalgia sufferers often feel that they are "wearing their nerves on their skin." Nerve conditions cause the skin to be extremely sensitive to touch, cold temperatures and wind. Generic mestinon, or pyridostigmine, is available in 60 mg tablets. Slow-release mestinon tablets are available in 180 mg. The 60 mg syrup, per teaspoon, contains pyridostigmine bromide, alcohol, lactic acid, glycerin, sodium benzoate, sorbitol, sucrose, food coloring and flavors. Watson Pharmaceuticals, Inc. began manufacturing mestinon after Solvay Pharmaceutical‘s withdrawal of the drug from the FDA. Other drug manufacturers who also make mestinon include ICN Pharmaceuticals, Inc. and Valeant Pharmaceuticals International.

The dosages are 60 mg tablets and a time-released 180 mg tablet. Some of the side effects associated with mestinon include nausea, increased saliva and other gastrointestinal symptoms. Some symptoms, such as skin rash, may subside with extended use of the drug. Overdosing on mestinon affects the muscles which could result in death due to decreased lung function. A physician will decide if the side effects of this drug are worth the risk in pregnant women. Report any unexpected side effects to a physician. Always talk with a physician before beginning any new medication.